Tuesday - June 30, 2026
Johnson & Johnson Begins Enrollment in Pivotal Studies Evaluating First-of-its-Kind Carotid IVL Platform
June 26, 2026
NEW BRUNSWICK, New Jersey, June 26 [Category: BizHealth & Beauty] (TNSxrep) -- Johnson and Johnson posted the following news release:

* * *

Johnson & Johnson Begins Enrollment in Pivotal Studies Evaluating First-of-its-Kind Carotid IVL Platform

*

SANTA CLARA, Calif. - June 25, 2026 - Johnson & Johnson announced today the initiation of its SKYWARD investigational device exemption (IDE) clinical program evaluating the novel Shockwave . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products